Announced Tue, 5 Aug · 17:29 IST

Star Health And Allied Insurance Company Limited has informed the Exchange about Transcript

Mgmt Guided Margin ImprovementMgmt Guided Margin PressureMgmt Evaded Key QuestionInvestor Communications View source PDF

STARHEALTH · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

Star Health reported Q1 FY2026 Gross Written Premium of Rs. 3,936 crores, up 13% year-on-year, with retail health GWP growing 18% to Rs. 3,667 crores and fresh retail premiums rising 25%. The company maintained its 31% market share in retail health and an impressive 98% premium persistency. IFRS Profit After Tax jumped 44% YoY to Rs. 438 crores, while the combined ratio stood at 99.6% and the net incurred claim ratio at 69.5%, slightly higher than last year. The expense ratio improved by 100 basis points to 30.1%, and solvency remained strong at 2.22x. Investment income grew to Rs. 586 crores, including Rs. 292 crores of mark-to-market gains. Management reaffirmed its FY2028 IFRS PAT target of Rs. 2,500 crores (with 20% from underwriting and 80% from investments) and indicated the Rs. 30,000 crore GWP target may be moderated due to the corporate business exit. New Chairperson Rajeev Kher was appointed, and COO Amitabh Jain and CMO Himanshu Walia were elevated to the Board.

Likely market impact

Strong retail growth and a 44% PAT jump are positives, but the slightly elevated claim ratio (69.5% vs 68.1%) and dependence on MTM gains for profit growth may temper near-term investor enthusiasm. The reaffirmation of long-term FY2028 targets and expense ratio improvement should support confidence in margin trajectory.